Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Chris Pargellis
Institution:
Boehringer Ingelheim (United States)
Observed institution:
Boehringer Ingelheim (United States)
OpenAlex ID:
A5111849635
Pyrazole Urea-Based Inhibitors of p38 MAP Kinase: From Lead Compound to Clinical Candidate
2002
·
John Regan
, Steffen Breitfelder
, et al.
·
Journal of Medicinal Chemistry
·
373
BIRB 796 enhances cytotoxicity triggered by bortezomib, heat shock protein (Hsp) 90 inhibitor, and dexamethasone via inhibition of p38 mitogen‐activated protein kinase/Hsp27 pathway in multiple myeloma cell lines and inhibits paracrine tumour growth
2006
·
Hiroshi Yasui
, Teru Hideshima
, et al.
·
British Journal of Haematology
·
66
PDF
Synthesis and SAR studies of indole-based MK2 inhibitors
2008
·
Zhaoming Xiong
, Donghong Amy Gao
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
42
BIRB796 Inhibits p38 MAPK/Hsp27 Pathway and Enhances Cytotoxicity Triggered by Bortezomib, Hsp90 Inhibitor, and Dexamethasone in Multiple Myeloma.
2006
·
Hiroshi Yasui
, Teru Hideshima
, et al.
·
Blood
Show more works
View as search
Works count:
4
Citation count:
481
H-index:
3
I10-index:
3
Year
Topic
Type